Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06511050
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-16
Brief Title:
Lumbrokinase for Long Covid Clinical Trial
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Investigating the Effects of Lumbrokinase in Adults With Long Covid Post-treatment Lyme Disease Syndrome and Myalgic EncephalomyelitisChronic Fatigue Syndrome
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This will be a pilot multi-arm clinical trial investigating the feasibility of Lumbrokinase LK as an intervention in three clinical cohorts
Long Covid LC
Post-treatment Lyme disease syndrome PTLDS
Myalgic encephalomyelitischronic fatigue syndrome MECFS
Long Covid LC
Post-treatment Lyme disease syndrome PTLDS
Myalgic encephalomyelitischronic fatigue syndrome MECFS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None